guanabenz has been researched along with Choroid Neovascularization in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hara, H; Imai, T; Inoue, Y; Takahashi, K; Tanaka, M; Tanida, N | 1 |
1 other study(ies) available for guanabenz and Choroid Neovascularization
Article | Year |
---|---|
Guanabenz and Clonidine, α2-Adrenergic Receptor Agonists, Inhibit Choroidal Neovascularization.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Cell Movement; Cell Proliferation; Choroidal Neovascularization; Clonidine; Disease Models, Animal; Endothelial Cells; Guanabenz; Humans; Male; Mice; Retina; Treatment Outcome; Vascular Endothelial Growth Factor A | 2021 |